日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma

FLIPI24:一种用于新诊断滤泡性淋巴瘤的现代预后模型和临床试验富集工具

Maurer, Matthew J; Prochazka, Vit K; El-Galaly, Tarec Christoffer; Flowers, Christopher R; Villa, Diego; Bachy, Emmanuel; Cahn, Elliot J; Fournier, Marguerite; Larson, Melissa C; Dietrich, Caroline E; Jakobsen, Lasse Hjort; Ghesquières, Hervé; Kridel, Robert; Gandhi, Maher K; Cheah, Chan Y; Hawkes, Eliza A; Seymour, John F; Freeman, Ciara L; Clausen, Michael R; Wahlin, Björn E; Friedberg, Jonathan W; Casulo, Carla; Habermann, Thomas M; Wang, Yucai; Nastoupil, Loretta J; de Nully Brown, Peter; Belada, David; Janíková, Andrea; Mocikova, Heidi; Fürst, Tomáš; Feugier, Pierre; Tilly, Hervé; Haioun, Corinne; Davies, Andrew J; Cartron, Guillaume; Burack, Richard; Chihara, Dai; Martin, Peter; Cohen, Jonathon B; Lossos, Izidore S; Kahl, Brad S; Sehn, Laurie H; Smedby, Karin E; Salles, Gilles; Trneny, Marek; Link, Brian K; Morschhauser, Franck; Cerhan, James R

Outcomes of bispecific antibodies after CAR T-cell failure for large B-cell lymphoma: results from the ABC consortium

CAR-T细胞疗法治疗大B细胞淋巴瘤失败后双特异性抗体的疗效:来自ABC联盟的研究结果

Melody, Megan; Grover, Natalie; Franco, Stephanie; Romancik, Jason; Cortese, Matthew; Moyo, Tamara K; Bhansali, Rahul S; Ollila, Thomas; Kenkre, Vaishalee; Fitzgerald, Lindsey; Hess, Brian; Matasar, Matt; Shouse, Geoffrey; Annunzio, Kaitlin; Herr, Megan M; Davis, James A; Jesme, Christy; Pelcovits, Ari; Moreira, Jonathan; Ma, Shuo; Winter, Jane N; Lin, Adam; Danilov, Alexey; Roy, Ishan; Barta, Stefan K; Gordon, Leo I; Stephens, Deborah; Cohen, Jonathon B; Epperla, Narendranath; Karmali, Reem

Outcomes for CART as 2L vs 3L vs 4L or beyond in aggressive B-cell lymphoma: real-world evidence from the ABC Consortium

CAR-T方案作为侵袭性B细胞淋巴瘤二线、三线、四线及以上治疗的疗效:来自ABC联盟的真实世界证据

Wang, John S; Ellsworth, Brandon L; Melody, Megan; Epperla, Narendranath; Stephens, Deborah; Romancik, Jason; Cortese, Matthew; Bhansali, Rahul; Moyo, Tamara K; Kenkre, Vaishalee; Ollila, Thomas; Hess, Brian; Fitzgerald, Lindsey; Shouse, Geoffrey; Matasar, Matthew; Herr, Megan M; Davis, James; Jesme, Christy; Pelcovits, Ari R; Moreira, Jonathan; Lin, Adam Y; Ma, Shuo; Winter, Jane N; Danilov, Alexey V; Shah, Nirav N; Barta, Stefan K; Cohen, Jonathon B; Gordon, Leo I; Grover, Natalie; Karmali, Reem

Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma

利妥昔单抗维持治疗对一线苯达莫司汀-利妥昔单抗治疗后套细胞淋巴瘤患者的益处

Wang, Yucai; Larson, Melissa C; Hwang, Steven R; Villa, Diego; Kugathasan, Laveniya; Kumar, Anita; Joseph, Ashlee; Brooks, Taylor R; Hill, Brian T; Bond, David A; Maddocks, Kami J; Nizamuddin, Imran A; Kahl, Brad S; Danilov, Alexey; Argao, Christine; Ruan, Jia; Ryan, Christine E; Merryman, Reid W; Grover, Natalie S; Khan, Nazneen B; Ouchveridze, Evguenia; Tun, Aung M; Ayyappan, Sabarish; Mou, Eric; Pongas, Georgios N; Lossos, Izidore S; Harris, Zoey I; Munoz, Javier L; Young, Philip; Portell, Craig A; Baidoun, Firas; Alhaj Moustafa, Muhamad; Reagan, Patrick M; Banaszak, Lauren G; Pophali, Priyanka A; Velayati, Arash; Greenwell, I Brian; Gerber, Drew; Jain, Preetesh; Wang, Michael L; Narkhede, Mayur S; Mehta, Amitkumar; Stack, Anthony C; Messmer, Marcus R; Bhansali, Rahul S; Barta, Stefan K; Moyo, Tamara K; Ghosh, Nilanjan; Kamdar, Manali K; Anna, Jacob; Stanisic, Alexander V; Karmali, Reem; Maurer, Matthew J; Cerhan, James R; Cohen, Jonathon B; Martin, Peter

Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R marginal zone lymphoma: phase 1/2 BRUIN study

Pirtobrutinib,一种高选择性、非共价(可逆)BTKi,用于治疗复发/难治性边缘区淋巴瘤:BRUIN 1/2期研究

Patel, Krish; Vose, Julie M; Nasta, Sunita D; Brown, Jennifer R; Maddocks, Kami J; Woyach, Jennifer A; Shah, Nirav N; Fakhri, Bita; Tessoulin, Benoit; Ma, Shuo; Jagadeesh, Deepa; Lech-Maranda, Ewa; Coombs, Catherine C; Patel, Manish R; Rhodes, Joanna M; Ujjani, Chaitra; Hoffmann, Marc S; Cheah, Chan Y; Munir, Talha; Lewis, David; Scarfò, Lydia; Eyre, Toby A; Alencar, Alvaro; Cohen, Jonathon B; Zelenetz, Andrew D; Tsai, Donald E; Li, Mei; Bian, Yuanyuan; Abada, Paolo; Balbas, Minna; Zinzani, Pier Luigi

Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy

双重打击和双重表达淋巴瘤:CD19靶向CAR T细胞疗法生存结果的多中心分析

Karmali, Reem; Shouse, Geoffrey; Torka, Pallawi; Moyo, Tamara K; Romancik, Jason; Barta, Stefan K; Bhansali, Rahul; Cohen, Jonathon B; Shah, Nirav N; Zurko, Joanna; Kenkre, Vaishalee P; Hess, Brian; Stephens, Deborah M; Fitzgerald, Lindsey; Ollila, Thomas; Tabiti, Bukky; Roy, Ishan; Ma, Shuo; Winter, Jane; Pro, Barbara; Moreira, Jonathan; Danilov, Alexey V; David, Kevin; Gordon, Leo I; Epperla, Narendranath

Phase II study of venetoclax added to bendamustine and obinutuzumab in patients with high-risk follicular lymphoma as front-line therapy: PrE0403

一项针对高危滤泡性淋巴瘤患者的一线治疗方案的 II 期研究:维奈克拉联合苯达莫司汀和奥妥珠单抗:PrE0403

Portell, Craig A; Jegede, Opeyemi A; Wagner-Johnston, Nina; Nowakowski, Grzegorz S; Fletcher, Christopher; Cohen, Jonathon B; Evens, Andrew M; Rosenstein, Lori J; Craig, Jeffrey W; Reddy, Nishitha; Kahl, Brad S

Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study

采用R-GemOx方案治疗复发或难治性弥漫性大B细胞淋巴瘤的疗效:一项多中心队列研究

Yamshon, Samuel; Koff, Jean L; Larson, Melissa C; Kahl, Brad S; Casulo, Carla; Lossos, Izidore S; Haddadi, Sara; Stanchina, Michele; Chihara, Dai; Ayers, Amy; Habermann, Thomas M; Wang, Yucai; Khurana, Arushi; Nowakowski, Grzegorz S; Reicks, Tanner W; Farooq, Umar; Link, Brian K; Cohen, Jonathon B; Martin, Peter; Li, Jia; Shewade, Ashwini; Batlevi, Connie Lee; Lo-Rossi, Andrea; Fox, David; Masaquel, Anthony; Mun, Yong; Cerhan, James R; Flowers, Christopher R; Maurer, Matthew J; Nastoupil, Loretta J

PD-1 expression identifies proliferating malignant CLL B cells and is a potential biomarker of response to BTK inhibitor therapy

PD-1表达可识别增殖的恶性CLL B细胞,并且是BTK抑制剂治疗反应的潜在生物标志物。

Chang, Andres; Pelletier, Adam N; McGuire, Donald J; Tsagiopoulou, Maria; Karipidou, Maria; Ayers, Amy; Leal, Alyssa M K; Churnetski, Michael C; O'Leary, Colin B; Switchenko, Jeffrey M; Davis, Carl; Frank, David A; Koff, Jean L; Cohen, Jonathon B; Sekaly, Rafick P; Stamatopoulos, Kostas; Flowers, Christopher R; Ahmed, Rafi

Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial

在对布鲁顿酪氨酸激酶抑制剂不耐受的B细胞恶性肿瘤患者中,吡托布鲁替尼单药治疗:I/II期BRUIN试验结果

Shah, Nirav N; Wang, Michael; Roeker, Lindsey E; Patel, Krish; Woyach, Jennifer A; Wierda, William G; Ujjani, Chaitra S; Eyre, Toby A; Zinzani, Pier Luigi; Alencar, Alvaro J; Ghia, Paolo; Lamanna, Nicole; Hoffmann, Marc S; Patel, Manish R; Flinn, Ian; Gerson, James N; Ma, Shuo; Coombs, Catherine C; Cheah, Chan Y; Lech-Maranda, Ewa; Fakhri, Bita; Kim, Won Seog; Barve, Minal A; Cohen, Jonathon B; Jurczak, Wojciech; Munir, Talha; Thompson, Meghan C; Tsai, Donald E; Bao, Katherine; Cangemi, Nicholas A; Kherani, Jennifer F; Walgren, Richard A; Han, Hongmei; Ruppert, Amy S; Brown, Jennifer R